Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.637,80
0,67%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Akari Therapeutics PLC (AKTX) Akari Therapeutics PLC (AKTX) Notizie

Akari Therapeutics PLC

AKTX
3,16
0,11 (3,61%)
14 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/6/202400:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
05/6/202423:00EDGAR2Form 8-K - Current report
04/6/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202414:02EDGAR2Form 8-K - Current report
03/6/202422:21EDGAR2Form DEF 14A - Other definitive proxy statements
16/5/202414:05EDGAR2Form 8-K - Current report
15/5/202422:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202423:05EDGAR2Form 8-K - Current report
15/3/202417:53PRNUSKuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to..
11/3/202422:25EDGAR2Form 425 - Prospectuses and communications, business..
11/3/202422:24EDGAR2Form 8-K - Current report
05/3/202422:57EDGAR2Form 425 - Prospectuses and communications, business..
05/3/202414:34EDGAR2Form 425 - Prospectuses and communications, business..
05/3/202414:28EDGAR2Form 8-K - Current report
09/1/202423:25EDGAR2Form D - Notice of Exempt Offering of Securities
04/1/202418:34EDGAR2Form SC 13D/A - General statement of acquisition of..
03/1/202401:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202401:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202400:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202400:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202422:30EDGAR2Form 8-K - Current report
01/12/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202322:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/10/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
20/10/202322:29EDGAR2Form POS AM - Post-Effective amendments for registration..
20/10/202322:28EDGAR2Form POS AM - Post-Effective amendments for registration..
20/10/202322:23EDGAR2Form F-3 - Registration statement by foreign private issuers
12/10/202322:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/9/202314:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202315:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/8/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/8/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/7/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/7/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/7/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/6/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 3,06 Min: 2,975 Max: 3,29
Chiusura: 3,05

La tua Cronologia

NASDAQ
AKTX
Akari Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network